These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19578232)

  • 1. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
    Zanini B; Lanzini A
    Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difficulties with interferon treatment in former intravenous drug users.
    Gazdag G; Horváth G; Szabó O; Ungvari GS
    Braz J Infect Dis; 2011; 15(2):163-6. PubMed ID: 21503405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies.
    Zanini B; Covolo L; Donato F; Lanzini A
    Clin Ther; 2010 Dec; 32(13):2139-59. PubMed ID: 21316533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.
    Corson S; Greenhalgh D; Palmateer N; Weir A; Hutchinson S
    Int J Drug Policy; 2011 Mar; 22(2):102-8. PubMed ID: 21112759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for hepatitis C virus infection among current injection drug users in Australia.
    Matthews G; Kronborg IJ; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C treatment uptake and adherence among injecting drug users in the Czech Republic.
    Mravčík V; Strada L; Reimer J; Schulte B
    Epidemiol Mikrobiol Imunol; 2014 Nov; 63(4):265-9. PubMed ID: 25523218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C in drug addicts: access and treatment compliance].
    Sarmento E Castro R; Valente C; Ramos JP; Almeida JR; Marinho RT; Branco T; Andrade S; Macedo A
    Acta Med Port; 2011 Dec; 24 Suppl 2():483-92. PubMed ID: 22849938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.
    Alvarez-Uria G; Day JN; Nasir AJ; Russell SK; Vilar FJ
    Liver Int; 2009 Aug; 29(7):1051-5. PubMed ID: 19580634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.
    Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I
    Int J Drug Policy; 2017 Sep; 47():209-215. PubMed ID: 28587943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
    Manolakopoulos S; Deutsch MJ; Anagnostou O; Karatapanis S; Tiniakou E; Papatheodoridis GV; Georgiou E; Manesis E; Tzourmakliotis D; Archimandritis AJ
    Liver Int; 2010 Nov; 30(10):1454-60. PubMed ID: 20846344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
    Grebely J; Dalgard O; Conway B; Cunningham EB; Bruggmann P; Hajarizadeh B; Amin J; Bruneau J; Hellard M; Litwin AH; Marks P; Quiene S; Siriragavan S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Dillon JF; Read P; Gane E; Dore GJ;
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):153-161. PubMed ID: 29310928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinfection with hepatitis C virus following sustained virological response in injection drug users.
    Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1281-4. PubMed ID: 20594256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
    Ueno Y; Sollano JD; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.
    Bruggmann P; Blach S; Deltenre P; Fehr J; Kouyos R; Lavanchy D; Müllhaupt B; Rauch A; Razavi H; Schmid P; Semela D; Stoeckle M; Negro F
    Swiss Med Wkly; 2017; 147():w14543. PubMed ID: 29120012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users.
    Brown K; Crofts N
    Aust N Z J Public Health; 1998; 22(3 Suppl):384-8. PubMed ID: 9629827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction.
    McCance-Katz EF; Valdiserri RO
    Ann Intern Med; 2015 Aug; 163(3):224-5. PubMed ID: 26120801
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
    Schaefer M; Heinz A; Backmund M
    Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.